HUI Working Papers,
HUI Research

Abstract: In this paper, the impact of increased information on brand name and generic pharmaceutical prices is analyzed both theoretically and empirically. The theoretical results show that an increase in information is likely to reduce the price of brand name pharmaceuticals, while the results regarding generics are less clear. In the empirical part of the paper, the introduction of the substitution reform in the Swedish pharmaceuticals market in October 2002 is used as a natural experiment regarding the effects of increased consumer information on pharmaceutical prices. The results clearly show that the reform has lowered the price of both brand name- and generic pharmaceuticals.

Keywords: Pharmaceutical industry; generic competition; generic drugs; brand name drugs

JEL-codes: D80; D83; I11; L65

32 pages, April 1, 2007

Download statistics

Published as

David Granlund and Niklas Rudholm, (2011), 'Consumer Information and Pharmaceutical Prices: Theory and Evidence', Oxford Bulletin of Economics and Statistics, vol 73, no 2, pages 230-254

• HUI Research
• Ordering Working Papers
• Home page for this series

Questions (including download problems) about the papers in this series should be directed to Hans Seerar Westerberg ()
Report other problems with accessing this service to Sune Karlsson ().

RePEc:hhs:huiwps:0008This page generated on 2024-09-13 22:15:09.